48 related articles for article (PubMed ID: 16271264)
1. Placental passage of tricyclic antidepressants.
Loughhead AM; Stowe ZN; Newport DJ; Ritchie JC; DeVane CL; Owens MJ
Biol Psychiatry; 2006 Feb; 59(3):287-90. PubMed ID: 16271264
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Antidepressants in Pregnancy.
Yue M; Kus L; Katta S; Su I; Li L; Haas DM; Quinney SK
J Clin Pharmacol; 2023 Jun; 63 Suppl 1(Suppl 1):S137-S158. PubMed ID: 37317494
[TBL] [Abstract][Full Text] [Related]
3. Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997-2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014-2018).
Fisher SC; Howley MM; Tran EL; Ailes EC; Papadopoulos EA; Nembhard WN; Browne ML;
Pharmacoepidemiol Drug Saf; 2023 Aug; 32(8):855-862. PubMed ID: 36942828
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis.
Schoretsanitis G; Westin AA; Stingl JC; Deligiannidis KM; Paulzen M; Spigset O
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110228. PubMed ID: 33358964
[TBL] [Abstract][Full Text] [Related]
5. Depressive symptoms during pregnancy and postpartum in women and use of antidepressant treatment - a longitudinal cohort study.
Sunnqvist C; Sjöström K; Finnbogadóttir H
Int J Womens Health; 2019; 11():109-117. PubMed ID: 30799960
[TBL] [Abstract][Full Text] [Related]
6. Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research.
Sujan AC; Öberg AS; Quinn PD; D'Onofrio BM
J Child Psychol Psychiatry; 2019 Apr; 60(4):356-376. PubMed ID: 30515808
[TBL] [Abstract][Full Text] [Related]
7. Maternal SSRIs experience and risk of ASD in offspring: a review.
Fatima Z; Zahra A; Ghouse M; Wang X; Yuan Z
Toxicol Res (Camb); 2018 Nov; 7(6):1020-1028. PubMed ID: 30510676
[TBL] [Abstract][Full Text] [Related]
8. Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women.
Filgueira GCO; Filgueira OAS; Carvalho DM; Marques MP; Moisés ECD; Duarte G; Lanchote VL; Cavalli RC
Br J Clin Pharmacol; 2017 Jul; 83(7):1571-1579. PubMed ID: 28042936
[TBL] [Abstract][Full Text] [Related]
9. Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid.
Fokina VM; West H; Oncken C; Clark SM; Ahmed MS; Hankins GD; Nanovskaya TN
Am J Obstet Gynecol; 2016 Oct; 215(4):497.e1-7. PubMed ID: 27180885
[TBL] [Abstract][Full Text] [Related]
10. Maternal exposure to carbamazepine at environmental concentrations can cross intestinal and placental barriers.
Kaushik G; Huber DP; Aho K; Finney B; Bearden S; Zarbalis KS; Thomas MA
Biochem Biophys Res Commun; 2016 May; 474(2):291-295. PubMed ID: 27105911
[TBL] [Abstract][Full Text] [Related]
11. A neonatal prolonged QT syndrome due to maternal use of oral tricyclic antidepressants.
Fukushima N; Nanao K; Fukushima H; Namera A; Miura M
Eur J Pediatr; 2016 Aug; 175(8):1129-32. PubMed ID: 27068648
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage.
Marinelli C; Bertalot T; Zusso M; Skaper SD; Giusti P
Front Cell Neurosci; 2016; 10():27. PubMed ID: 26903812
[TBL] [Abstract][Full Text] [Related]
13. Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation.
Ram D; Gandotra S
Indian J Psychiatry; 2015 Jul; 57(Suppl 2):S354-71. PubMed ID: 26330654
[TBL] [Abstract][Full Text] [Related]
14. Placental transfer of antidepressant medications: implications for postnatal adaptation syndrome.
Ewing G; Tatarchuk Y; Appleby D; Schwartz N; Kim D
Clin Pharmacokinet; 2015 Apr; 54(4):359-70. PubMed ID: 25711391
[TBL] [Abstract][Full Text] [Related]
15. Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro.
Fan LW; Bhatt A; Tien LT; Zheng B; Simpson KL; Lin RC; Cai Z; Kumar P; Pang Y
J Neurochem; 2015 May; 133(4):532-43. PubMed ID: 25382136
[TBL] [Abstract][Full Text] [Related]
16. Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.
El Marroun H; White T; Verhulst FC; Tiemeier H
Eur Child Adolesc Psychiatry; 2014 Oct; 23(10):973-92. PubMed ID: 24863148
[TBL] [Abstract][Full Text] [Related]
17. Prenatal antidepressant exposure: clinical and preclinical findings.
Bourke CH; Stowe ZN; Owens MJ
Pharmacol Rev; 2014; 66(2):435-65. PubMed ID: 24567054
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo perfusion of mid-to-late-gestation mouse placenta for maternal-fetal interaction studies during pregnancy.
Goeden N; Bonnin A
Nat Protoc; 2013 Jan; 8(1):66-74. PubMed ID: 23237830
[TBL] [Abstract][Full Text] [Related]
19. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
Sit D; Perel JM; Wisniewski SR; Helsel JC; Luther JF; Wisner KL
J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
[TBL] [Abstract][Full Text] [Related]
20. Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1: Literature review.
Nijenhuis CM; Horst PG; Berg LT; Wilffert B
Br J Clin Pharmacol; 2012 Jan; 73(1):16-26. PubMed ID: 21815911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
